272 related articles for article (PubMed ID: 36183165)
21. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.
Putcharoen O; Wacharapluesadee S; Chia WN; Paitoonpong L; Tan CW; Suwanpimolkul G; Jantarabenjakul W; Ruchisrisarod C; Wanthong P; Sophonphan J; Chariyavilaskul P; Wang LF; Hemachudha T
PLoS One; 2021; 16(2):e0246864. PubMed ID: 33577615
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
[TBL] [Abstract][Full Text] [Related]
23. Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.
Santos da Silva E; Servais JY; Kohnen M; Arendt V; Staub T; The Con-Vince Consortium ; The CoVaLux Consortium ; Krüger R; Fagherazzi G; Wilmes P; Hübschen JM; Ollert M; Perez-Bercoff D; Seguin-Devaux C
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834413
[TBL] [Abstract][Full Text] [Related]
24. Development of monoclonal antibody-based blocking ELISA for detecting SARS-CoV-2 exposure in animals.
Yuan F; Chen C; Covaleda LM; Martins M; Reinhart JM; Sullivan DR; Diel DG; Fang Y
mSphere; 2023 Aug; 8(4):e0006723. PubMed ID: 37409816
[TBL] [Abstract][Full Text] [Related]
25. The dynamics of neutralizing antibodies against SARS-CoV-2 in cats naturally exposed to virus reveals an increase in antibody activity after re-infection.
Villanueva-Saz S; Martínez M; Rueda P; Bolea S; Pérez MD; Verde M; Yzuel A; Hurtado-Guerrero R; Pardo J; Santiago L; Fernández A; Arias M
Vet Res Commun; 2023 Dec; 47(4):2179-2184. PubMed ID: 36918467
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 antibody response dynamics and heterogeneous diagnostic performance of four serological tests and a neutralization test in symptomatic healthcare workers with non-severe COVID-19.
Ong DSY; Keuren F; van der Vliet M; Boxma-de Klerk BM; Koeleman JGM
J Clin Virol; 2021 Aug; 141():104904. PubMed ID: 34229209
[TBL] [Abstract][Full Text] [Related]
27. Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands.
Zhao S; Schuurman N; Li W; Wang C; Smit LAM; Broens EM; Wagenaar JA; van Kuppeveld FJM; Bosch BJ; Egberink H
Emerg Infect Dis; 2021 May; 27(5):1362-1370. PubMed ID: 33900184
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
[TBL] [Abstract][Full Text] [Related]
29. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern Spain.
Fernández-Bastit L; Marfil S; Pradenas E; Valle R; Roca N; Rodon J; Pailler-García L; Trinité B; Parera M; Noguera-Julian M; Martorell J; Izquierdo-Useros N; Carrillo J; Clotet B; Blanco J; Vergara-Alert J; Segalés J
Transbound Emerg Dis; 2022 Nov; 69(6):3518-3529. PubMed ID: 36167932
[TBL] [Abstract][Full Text] [Related]
30. A cross-sectional serosurvey of SARS-CoV-2 and co-infections in stray cats from the second wave to the sixth wave of COVID-19 outbreaks in Spain.
Villanueva-Saz S; Martínez M; Giner J; González A; Tobajas AP; Pérez MD; Lira-Navarrete E; González-Ramírez AM; Macías-León J; Verde M; Yzuel A; Hurtado-Guerrero R; Arias M; Santiago L; Aguiló-Gisbert J; Ruíz H; Lacasta D; Marteles D; Fernández A
Vet Res Commun; 2023 Jun; 47(2):615-629. PubMed ID: 36229725
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test.
Bal A; Pozzetto B; Trabaud MA; Escuret V; Rabilloud M; Langlois-Jacques C; Paul A; Guibert N; D'Aubarède-Frieh C; Massardier-Pilonchery A; Fabien N; Goncalves D; Boibieux A; Morfin-Sherpa F; Pitiot V; Gueyffier F; Lina B; Fassier JB; Trouillet-Assant S;
Clin Chem; 2021 Apr; 67(5):742-752. PubMed ID: 33399823
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of exposure to SARS-CoV-2 in domestic dogs and cats and its relationship with COVID-19 cases in the city of Villavicencio, Colombia.
Jaramillo Hernández DA; Chacón MC; Velásquez MA; Vásquez-Trujillo A; Sánchez AP; Salazar Garces LF; García GL; Velasco-Santamaría YM; Pedraza LN; Lesmes-Rodríguez LC
F1000Res; 2022; 11():1184. PubMed ID: 37965037
[No Abstract] [Full Text] [Related]
33. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma.
Klaus J; Palizzotto C; Zini E; Meli ML; Leo C; Egberink H; Zhao S; Hofmann-Lehmann R
Viruses; 2021 Mar; 13(3):. PubMed ID: 33806922
[TBL] [Abstract][Full Text] [Related]
35. A serological survey of severe acute respiratory syndrome coronavirus 2 in dogs in Wuhan.
Zhao Y; Yang Y; Gao J; Huang K; Hu C; Hui X; He X; Li C; Gong W; Lv C; Zhang Y; Chen H; Zou Z; Zhang Q; Jin M
Transbound Emerg Dis; 2022 Mar; 69(2):591-597. PubMed ID: 33550715
[TBL] [Abstract][Full Text] [Related]
36. Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2.
Kweon OJ; Bae JY; Lim YK; Choi Y; Lee S; Park MS; Suh IB; Kim H; Jee YS; Lee MK
Sci Rep; 2023 Mar; 13(1):4961. PubMed ID: 36973368
[TBL] [Abstract][Full Text] [Related]
37. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects.
Gillot C; Favresse J; Maloteau V; Dogné JM; Douxfils J
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835135
[TBL] [Abstract][Full Text] [Related]
39. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
[TBL] [Abstract][Full Text] [Related]
40. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
